The risk of subsequent osteoporotic fractures is decreased in subjects experiencing fracture while on denosumab: results from the FREEDOM and FREEDOM Extension studies
FI: 3,83
Type: Article
Collaboration
Year: 2019
Writers
Kendler, D.L.; Chinas, A; Brandy, M.L.; Papapoulos, S; Lewiecki, EM; Reginster, JY; Towers, M.M.; Wang, A; Bone, H.G.
Magazine
Title: OSTEOPOROSIS INTERNATIONAL
Quartile
- Q2